Brussels, 12/03/2001 (Agence Europe) - The long phase of preparation for the revision of the European Union's pharmaceutical legislation, which we discussed last June (see EUROPE of 7 June 2000, p.12), is coming to an end.
In a discussion paper published last 22 January, the European Commission underlined that the revision of the pharmaceutical legislation is now following seven main avenues: - ensure a high level of protection for the health of European citizens, notably by making...